Handheld imaging for checking and monitoring mouth lesions

Reflectance confocal microscopy-optical coherence tomography (RCM-OCT) imaging of oral lesions: Toward an affordable device and approach for developing countries

NIH-funded research Sloan-Kettering Inst Can Research · NIH-11384192

Using a low-cost handheld device that takes detailed, noninvasive images of mouth lesions to help adults in low-income countries avoid unnecessary biopsies and find cancers earlier.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11384192 on NIH RePORTER

What this research studies

This project builds an affordable handheld device that combines two imaging methods (RCM and OCT) to capture both cellular detail at the surface and structural layers deeper in the mouth without cutting the tissue. Doctors will use the paired images plus a quantitative scoring algorithm to sort lesions into low-risk (watch or treat non-surgically) versus high-risk (biopsy or immediate treatment). The goal is to reduce painful, costly biopsies, improve follow-up, and catch cancers earlier by monitoring changes over time. Testing and refinement will occur in clinics, with a focus on low- and middle-income settings in Asia and sub-Saharan Africa.

Who could benefit from this research

Good fit: Adults (21+) with visible mouth lesions—such as red or white patches, ulcers, or indeterminate biopsy results—especially those in low- and middle-income regions, are the ideal candidates.

Not a fit: Children under 21, people with clearly invasive cancer requiring immediate surgery, or patients whose lesions cannot be reached by the handheld probe may not benefit from this imaging approach.

Why it matters

Potential benefit: Could reduce painful and costly biopsies, improve early detection of oral cancer, and enable non-surgical monitoring of low-risk lesions.

How similar studies have performed: Individual RCM and OCT studies in skin and mucosa have shown promise, but a single handheld RCM-OCT device with a quantitative scoring algorithm for oral lesions is a relatively new approach.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.